The Lancet Oncology · 2012 · 1.4K citations · 30 references
MedicineOncologyUrologyCancer PharmacologyMedical OncologyUrologic OncologyGenitourinary Cancer PharmacotherapyHormonal Cancer TherapyHormonal TherapyMetastatic Cancer ManagementMetastatic Disease TreatmentProstate CancerCastration-resistant Prostate Cancer TherapyMetastatic Castration-resistant Prostate CancerMetastatic Hormone-sensitive Prostate Cancer TherapyOverall MortalityPlacebo-controlled Efficacy AssessmentProstate Cancer Hormonal TherapyProstate Cancer Hormone TherapyProstate Cancer Prognosis
30
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Philip W. Kantoff, Celestia S. Higano, Neal D. Shore et al. · New England Journal of Medicine · 2010 · 5.5K citations · Full text
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2012 · 4.6K citations · Full text
Medicine, Oncology, Pharmacology +14
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. de Bono, Christopher J. Logothetis, Arturo Molina et al. · New England Journal of Medicine · 2011 · 4.4K citations · Full text
Medicine, Oncology, Pharmacology +17